Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

This study has been completed.
Information provided by (Responsible Party):
Marcia Brose, University of Pennsylvania Identifier:
First received: April 1, 2008
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)